Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,207 | $41,875 | $59,148 | $56,071 |
| - Cash | $8,697 | $12,101 | $14,539 | $13,048 |
| + Debt | $4,864 | $6,405 | $5,351 | $6,442 |
| Enterprise Value | $22,375 | $36,179 | $49,960 | $49,466 |
| Revenue | $2,688 | $3,472 | $5,325 | $6,044 |
| % Growth | -22.6% | -34.8% | -11.9% | – |
| Gross Profit | -$1,261 | $1,415 | $3,168 | $3,753 |
| % Margin | -46.9% | 40.8% | 59.5% | 62.1% |
| EBITDA | -$943 | -$973 | $700 | $1,523 |
| % Margin | -35.1% | -28% | 13.1% | 25.2% |
| Net Income | -$1,063 | -$1,643 | $21 | $857 |
| % Margin | -39.5% | -47.3% | 0.4% | 14.2% |
| EPS Diluted | -0.008 | -0.012 | 0 | 0.006 |
| % Growth | 36.7% | -12,100% | -98.4% | – |
| Operating Cash Flow | $60 | -$1,924 | $967 | $793 |
| Capital Expenditures | -$111 | -$195 | -$245 | -$203 |
| Free Cash Flow | -$51 | -$2,118 | $721 | $590 |